These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 19601551)
1. [Contribution of diuretics to the treatment of hypertension in patients with CKD]. Ura N; Yamaji I Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551 [No Abstract] [Full Text] [Related]
2. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease]. Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552 [No Abstract] [Full Text] [Related]
3. [Management of hypertension in CKD patients]. Kusaba T; Kimura K Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405 [TBL] [Abstract][Full Text] [Related]
4. [Principal entity of hypertension version of CKD guide]. Kimura G Nihon Jinzo Gakkai Shi; 2009; 51(4):442-5. PubMed ID: 19601550 [No Abstract] [Full Text] [Related]
5. Benefits and risks of combination therapy in hypertension. Node K Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269 [No Abstract] [Full Text] [Related]
6. Drugs for hypertension. Treat Guidel Med Lett; 2009 Jan; 7(77):1-10; quiz 2 p. PubMed ID: 19107095 [No Abstract] [Full Text] [Related]
7. [Debate concerning the optimal blockage of the renin-angiotensin system]. Choukroun G Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454 [No Abstract] [Full Text] [Related]
9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
10. Selecting antihypertensive medication in patients with essential hypertension in Malaysia. Ong HT; Rozina G Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313 [No Abstract] [Full Text] [Related]
11. [Renal effects of combined anti-hypertensive treatments]. Gallieni M; Olivi L; Mezzina N; Cozzolino M; Cusi D Recenti Prog Med; 2010 Feb; 101(2):70-7. PubMed ID: 20433005 [TBL] [Abstract][Full Text] [Related]
12. ACE inhibitors and ARBs: antihypertensive medications in CKD. Szromba C Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474 [No Abstract] [Full Text] [Related]
14. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)]. Dominiak P MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248 [No Abstract] [Full Text] [Related]
15. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade. Griffin KA; Bidani AK Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327 [TBL] [Abstract][Full Text] [Related]
16. [Therapy for hypertension associated with kidney disease]. Suzuki H Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731 [No Abstract] [Full Text] [Related]
17. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor]. Higashiura K; Shimamoto K Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698 [No Abstract] [Full Text] [Related]
18. ONTARGET still OFF-TARGET? Lambers Heerspink HJ; de Zeeuw D Circulation; 2011 Mar; 123(10):1049-51. PubMed ID: 21357820 [No Abstract] [Full Text] [Related]
19. Recent changes in the landscape of combination RAS blockade. Epstein BJ; Smith SM; Choksi R Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020 [TBL] [Abstract][Full Text] [Related]
20. ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression? Bakris GL J Clin Hypertens (Greenwich); 2007 Jun; 9(6):413-5. PubMed ID: 17541325 [No Abstract] [Full Text] [Related] [Next] [New Search]